TOT BIOPHARM International Co Ltd
HKEX:1875
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TOT BIOPHARM International Co Ltd
HKEX:1875
|
CN |
Cash Flow Statement
Cash Flow Statement
TOT BIOPHARM International Co Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(261)
|
0
|
(50)
|
0
|
(38)
|
0
|
35
|
0
|
|
| Depreciation & Amortization |
34
|
0
|
38
|
0
|
43
|
0
|
65
|
0
|
|
| Stock-Based Compensation |
5
|
0
|
16
|
0
|
11
|
0
|
6
|
0
|
|
| Other Non-Cash Items |
12
|
0
|
29
|
0
|
36
|
0
|
5
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
2
|
7
|
6
|
4
|
13
|
12
|
14
|
19
|
|
| Change in Working Capital |
40
|
(53)
|
43
|
93
|
15
|
22
|
11
|
123
|
|
| Cash from Operating Activities |
(175)
N/A
|
(53)
+70%
|
60
N/A
|
93
+56%
|
56
-40%
|
22
-61%
|
116
+433%
|
123
+6%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(115)
|
(118)
|
(240)
|
(308)
|
(203)
|
(146)
|
(124)
|
(81)
|
|
| Other Items |
7
|
2
|
(43)
|
4
|
39
|
(2)
|
1
|
0
|
|
| Cash from Investing Activities |
(108)
N/A
|
(116)
-7%
|
(283)
-143%
|
(304)
-8%
|
(164)
+46%
|
(148)
+10%
|
(123)
+17%
|
(80)
+35%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
204
|
171
|
80
|
81
|
54
|
52
|
48
|
12
|
|
| Other |
6
|
(7)
|
402
|
401
|
(16)
|
(12)
|
(14)
|
(19)
|
|
| Cash from Financing Activities |
212
N/A
|
165
-22%
|
481
+192%
|
482
+0%
|
38
-92%
|
40
+6%
|
34
-15%
|
(7)
N/A
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
(1)
|
3
|
7
|
7
|
3
|
1
|
2
|
(0)
|
|
| Net Change in Cash |
(73)
N/A
|
(1)
+98%
|
265
N/A
|
278
+5%
|
(66)
N/A
|
(85)
-28%
|
30
N/A
|
36
+20%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(290)
N/A
|
(171)
+41%
|
(180)
-6%
|
(214)
-19%
|
(147)
+32%
|
(124)
+15%
|
(7)
+94%
|
42
N/A
|
|